| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.37 | 2e-26 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-16 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-14 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-12 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |